Gene · 1445
Papers4,278
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,278
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer. | Cell Death Dis | 2023 | 37596261 | PubTator, text mining | PubMed |
| A novel hepatocellular carcinoma-specific mTORC1-related signature for anticipating prognosis and immunotherapy. | Aging (Albany NY) | 2023 | 37589508 | PubTator, text mining | PubMed |
| Gypsogenin Battling for a Front Position in the Pentacyclic Triterpenes Game of Thrones on Anti-Cancer Therapy: A Critical Review-Dedicated to the Memory of Professor Hanaa M. Rady. | Molecules | 2023 | 37570648 | PubTator, text mining | PubMed |
| Glucocorticoid Treatment in Acute Respiratory Distress Syndrome: An Overview on Mechanistic Insights and Clinical Benefit. | Int J Mol Sci | 2023 | 37569514 | PubTator, text mining | PubMed |
| Magneto-mechanical stimulation modulates osteocyte fate via the ECM-integrin-CSK axis and wnt pathway. | iScience | 2023 | 37554458 | PubTator, text mining | PubMed |
| Flipons and small RNAs accentuate the asymmetries of pervasive transcription by the reset and sequence-specific microcoding of promoter conformation. | J Biol Chem | 2023 | 37544644 | PubTator, text mining | PubMed |
| Editorial: Regulation and dysfunction of CSK and CHK. | Front Cell Dev Biol | 2023 | 37538399 | PubTator, text mining | PubMed |
| NF-kB's contribution to B cell fate decisions. | Front Immunol | 2023 | 37533858 | PubTator, text mining | PubMed |
| CSK-mediated signalling by integrins in cancer. | Front Cell Dev Biol | 2023 | 37519303 | PubTator, text mining | PubMed |
| Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus. | Clin Proteomics | 2023 | 37516862 | PubTator, text mining | PubMed |
| The Potential Role of Timosaponin-AIII in Cancer Prevention and Treatment. | Molecules | 2023 | 37513375 | PubTator, text mining | PubMed |
| The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies. | Molecules | 2023 | 37513232 | PubTator, text mining | PubMed |
| Revisiting Estrogen for the Treatment of Endocrine-Resistant Breast Cancer: Novel Therapeutic Approaches. | Cancers (Basel) | 2023 | 37509308 | PubTator, text mining | PubMed |
| High Density of N- and O-Glycosylation Shields and Defines the Structural Dynamics of the Intrinsically Disordered Ectodomain of Receptor-type Protein Tyrosine Phosphatase Alpha. | JACS Au | 2023 | 37502146 | PubTator, text mining | PubMed |
| TP53BP2: Roles in suppressing tumorigenesis and therapeutic opportunities. | Genes Dis | 2023 | 37492707 | PubTator, text mining | PubMed |
| The clinical significance of CD44v6 in malignant and benign primary bone tumors. | BMC Musculoskelet Disord | 2023 | 37491225 | PubTator, text mining | PubMed |
| HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy. | Front Immunol | 2023 | 37483605 | PubTator, text mining | PubMed |
| Identified Isosteric Replacements of Ligands' Glycosyl Domain by Data Mining. | ACS Omega | 2023 | 37483233 | PubTator, text mining | PubMed |
| SIX1 and EWS/FLI1 co-regulate an anti-metastatic gene network in Ewing Sarcoma. | Nat Commun | 2023 | 37468459 | PubTator, text mining | PubMed |
| Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor. | Nat Commun | 2023 | 37460463 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1445/papers?page=11